Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Entacapone Orion, entacapone, Date of authorisation: 18/08/2011, Revision: 11, Status: Authorised

Agenda of the HMPC meeting 23-25 September 2024

Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Authorised

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2024

What we publish on medicines and when

CHMP PROM minutes for the meeting on 17 June 2024

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 6, Status: Authorised